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Depression is associated with coronary heart disease and stroke, but associations with a
range of pathologically diverse cardiovascular diseases are not well understood. We exam-
ine the risk of 12 cardiovascular diseases according to depression status (history or new
onset).
Methods
Cohort study of 1,937,360 adult men and women, free from cardiovascular disease at base-
line, using linked UK electronic health records between 1997 and 2010. The exposures
were new-onset depression (a new GP diagnosis of depression and/or prescription for anti-
depressants during a one-year baseline), and history of GP-diagnosed depression before
baseline. The primary endpoint was initial presentation of 12 cardiovascular diseases after
baseline. We used disease-specific Cox proportional hazards models with multiple imputa-
tion adjusting for cardiovascular risk factors (age, sex, socioeconomic status, smoking,
blood pressure, diabetes, cholesterol).
Results
Over a median [IQR] 6.9 [2.1–10.5] years of follow-up, 18.9% had a history of depression
and 94,432 incident cardiovascular events occurred. After adjustment for cardiovascular
risk factors, history of depression was associated with: stable angina (Hazard Ratio = 1.38,
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95%CI 1.32–1.45), unstable angina (1.70, 1.60–1.82), myocardial infarction (1.21, 1.16–
1.27), unheralded coronary death (1.23, 1.14–1.32), heart failure (1.18, 1.13–1.24), cardiac
arrest (1.14, 1.03–1.26), transient ischemic attack (1.31, 1.25–1.38), ischemic stroke (1.26,
1.18–1.34), subarachnoid haemorrhage (1.17, 1.01–1.35), intracerebral haemorrhage
(1.30, 1.17–1.45), peripheral arterial disease (1.24, 1.18–1.30), and abdominal aortic aneu-
rysm (1.12,1.01–1.24). New onset depression developed in 2.9% of people, among whom
63,761 cardiovascular events occurred. New onset depression was similarly associated
with each of the 12 diseases, with no evidence of stronger associations compared to history
of depression. The strength of association between depression and these cardiovascular
diseases did not differ between women and men.
Conclusion
Depression was prospectively associated with cardiac, cerebrovascular, and peripheral dis-
eases, with no evidence of disease specificity. Further research is needed in understanding
the specific pathophysiology of heart and vascular disease triggered by depression in
healthy populations.
Introduction
Depression is a leading cause of disability worldwide and a major contributor to the global bur-
den of disease.[1] The prevalence of depression in primary care settings has been shown to
range between 5–10% in different countries.[2] Depression can have profound effects on social
functioning, quality of life, and physical health through associations with cardiovascular dis-
ease, the leading cause of preventable death worldwide.[3] Meta-analyses of cohort studies sug-
gest that depression is associated with 34–63% excess risk of all strokes combined[4–6] and
30–90% greater risk of aggregates of coronary heart disease.[6–9]
However, major clinical questions on the depression-cardiovascular disease hypothesis
remain unanswered. Firstly, whether associations show any specificity across pathologically
diverse cardiovascular diseases remains unclear. Cohort studies of depression have been too
small to evaluate less common diseases (such as subarachnoid haemorrhage or abdominal aor-
tic aneurysm)[10] or have lacked the clinical phenotyping[11] to report on common diseases
such as heart failure and peripheral arterial disease. As a result, no studies have been able to
directly compare the associations between depression and different cardiovascular diseases,
which may inform understanding of disease mechanisms. Instead, many studies, including
meta-analyses, have used aggregate endpoints [9,12,13] such as all types of stroke or all coro-
nary heart diseases.[8,10] Secondly, the clinician needs to know whether patients who have a
history of depression and patients diagnosed with new onset depression have similar or differ-
ential risks of subsequent cardiovascular diseases. This temporal resolution may point to differ-
ent bio-behavioural mechanisms. Thirdly, the extent to which women experience higher or
lower risk of any cardiovascular disease compared to men has not been reliably assessed.
Although women consistently have between 1.5–2.5 times greater prevalence rates of depres-
sion compared to men,[14] previous investigations have been too small to examine gender
modification in any associations with cardiovascular disease.[4] Lastly, there is a need to
understand the extent to which associations can be explained by conventional cardiovascular
risk factors. Cohort studies[11] as well as studies included in meta-analyses often have
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Answering these questions may contribute to the understanding of disease mechanisms and
inform clinical practice. We used a large contemporary population-based cohort derived from
linked electronic health records, including primary and secondary care, disease registry, and
death records.[15] These large scale data provide a higher resolution of the depression exposure
(distinguishing history and new onset) and of the outcome (distinguishing 12 chronic, acute,
fatal and non-fatal, cardiovascular diseases.)
Methods
Data sources
Anonymised patients were selected from the CALIBER (CArdiovascular research using LInked
Bespoke studies and Electronic Health Records) programme, described and validated else-
where.[15,16] In brief, patients were linked across four clinical record data sources: the Clinical
Practice Research Datalink (CPRD), the Myocardial Ischaemia National Audit Project
(MINAP) registry, Hospital Episodes Statistics (HES) and disease-specific mortality. CPRD
provides primary care data on clinical diagnoses, prescriptions, medical procedures, health
behaviours, anthropometric measurements, and laboratory tests, using the Read clinical coding
scheme[17], a hierarchical coding structure which maps onto ICD-10 codes and includes addi-
tional symptom and diagnostic codes. MINAP is a national registry of patients admitted to
hospital with an acute coronary syndrome. HES provides information on diagnoses and medi-
cal procedures related to all elective and emergency hospital admissions across all National
Health Service hospitals in England.
Study Population
Patients registered from 225 general practices were studied using an open cohort design. Fol-
low-up started on the date patients met the following eligibility criteria after 1 January 1997:
age 30 years or older, at least one year of pre-study follow-up within a CPRD general practice,
and free from clinically diagnosed cardiovascular diseases (any of the 12 cardiovascular out-
comes studied, see ‘cardiovascular risk factors‘). We used each patient’s entire medical history
available to confirm they were free from clinically diagnosed CVD. The look-back period ran-
ged from 20 years to the minimum of 1 year, which has been shown to be a sufficient period to
accrue accurate assessment of initial disease presentations.[18] Patients were censored on the
date of first cardiovascular disease presentation, death, or the date of last data collection from
the CPRD (20 March 2010), whichever occurred first.
A total of 2,135,617 patients met the eligibility criteria during the study period; of those,
198,257 had prior clinically diagnosed cardiovascular diseases or conditions and were
excluded.(See Table A in S1 File for detailed CVD definitions) Two cohorts were derived from
this population of 1,937,360 remaining patients. (Fig 1)
Cohort 1: History of depression
Among 1,937,360 patients, we defined history of depression as a CPRD record of a depression
diagnosis and/or prescription of anti-depressant medications at any point prior to baseline.
(Fig 1 Panel A) Those with no history of depression at any point prior to baseline were the ref-
erence group. Detailed information on specific Read codes used to define depression can be
found in Text A in S1 File.
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Fig 1. Cohort diagrams. (A) History of depression cohort (B) New onset depression cohort.
doi:10.1371/journal.pone.0153838.g001
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Cohort 2: New onset depression
We defined a baseline period as the one year between the date when patients meet inclusion
criteria and the beginning of cardiovascular endpoint follow-up. (Fig 1 Panel B) New onset
depression was defined as a CPRD record of a depression diagnosis and/or prescription of
anti-depressant medications (selective serotonin reuptake inhibitor, monoamine-oxidase
inhibitor, tricyclic, or other antidepressants) during this baseline period. Patients with no evi-
dence of depression during baseline were the reference group. Of the eligible 1,937,360, we
excluded patients with records of depression diagnosis, history of depression, antenatal depres-
sion, or anti-depressant prescriptions (n = 366,688) up to and including baseline. A further
214,094 had clinically diagnosed cardiovascular events the year following CPRD registration or
follow-up which did not extend to the cohort entry date, and were excluded. This derived a
cohort of 1,356,578 patients.
Cardiovascular risk factors
Socio-demographic and cardiovascular risk factors were obtained from CPRD, as recorded
during consultations in primary care. We used the most recent measurement (blood pressure,
lipids, body mass index) or prescription recorded up to one year prior to start of cardiovascular
endpoint follow-up. Socioeconomic status was defined using quintiles of the index of multiple
deprivation 2007, which provides a relative ranking of areas across England according to their
level of deprivation.[19] Read codes were used to define health behaviours (smoking status,
alcohol consumption.) We defined diabetes mellitus as prescription for oral hypoglycaemics or
insulin, or a diagnosis of diabetes. Full covariate definitions are provided at http://www.
caliberresearch.org/portal/.
Cardiovascular disease endpoints
Our primary endpoints were the first recorded diagnosis of the 12 most common presentations
of fatal or non-fatal cardiovascular disease (CVD) whether occurring in primary care, second-
ary care, or at death. We studied the following 12 CVDs: stable angina, unstable angina, non-
fatal myocardial infarction (MI), unheralded coronary heart disease death (death with the pri-
mary cause certified as coronary heart disease, and no prior history of cardiovascular disease,
including patients with myocardial infarction who died on the day of their infarct), heart fail-
ure, a composite of cardiac arrest, ventricular arrhythmia and sudden cardiac death (SCD),
transient ischemic attack, ischemic stroke, subarachnoid haemorrhage, intracerebral haemor-
rhage, abdominal aortic aneurysm, peripheral arterial disease, in addition to composite CVD.
We classified events as fatal where a death record existed for the same calendar date. We
defined the end of follow-up at first occurrence of the first cardiovascular endpoint diagnosis,
de-registration with the general practice, last data collection for the practice, or death from
non-cardiovascular causes. (See Table A in S1 File for an overview of diagnostic codes and data
sources used to define cardiovascular end points.)
Statistical analysis
To compare incidence of each of the 12 CVDs in the cohort according to GP-diagnosed depres-
sion status at baseline, we derived cumulative incidence rates per 100,000 person-years,
adjusted for the competing risk of presentations with other CVDs or death from other causes.
To derive hazard ratios (HR) and 95% confidence intervals for the association of depression
and 12 CVDs, we used disease-specific Cox proportional hazards models.[20] Models were
adjusted for age (linear and quadratic term), sex, social deprivation, smoking status, systolic
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blood pressure, total cholesterol, high-density lipoprotein, and diabetes, and stratified by pri-
mary care practice. To replace missing covariate data for variables not violating the missing at
random assumption, we implemented multiple imputation using themice[21] algorithm. (Full
description Text B in S1 File). Imputation models were estimated separately for men and
women and included baseline covariates, averages of continuous covariates within pre- and
post-baseline periods of up to 5 years, as well as measurements of blood pressure, creatinine,
and comorbid conditions. Five multiply imputed datasets were generated, and Cox models fit-
ted to each dataset. Estimates were combined using Rubin’s rules. Assuming mutual indepen-
dence between initial presentations, we assessed heterogeneity of the hazard ratios based on tau
(τ2), a moment-based statistic of the residual between-group variance.[22] Analysis was per-
formed using R version 15 for Unix and Stata 13.
Sensitivity analyses
Due to missing data for ethnicity and alcohol consumption in the CPRD, we repeated analyses
restricting the cohort to registrants with non-missing data (complete case.) Due to the known
excess risk of CVDs associated with diabetes[23], we excluded participants with diabetes at
baseline and repeated the analyses. In addition, all models were also repeated for new onset
depression as well as history of depression with adjustment for body mass index (BMI), in
addition to all other risk factors already adjusted for.
Results
Of 1,356,578 patients in with records during the one year baseline period, 39,747 (2.9%) had a
GP diagnosis of new onset depression. (Table 1) Over 63.0% were women, 92.8% identified as
white, and 22.9% were in the lowest socioeconomic group. Individuals with new-onset depres-
sion had higher prevalence of smoking, diabetes, use of anti-hypertensive medications, and
almost three-fold higher number of consultations in the past year compared to those without
depression at baseline. Out of 1,937,360 patients with records prior to the one year baseline,
367,117 (19.0%) had a GP diagnosis of history of depression.
Median (IQR) follow-up for CVDs was 6.9 (3.2–10.5) years. During 9,399,559 person-years
at risk, a total of 27,311 incident coronary heart disease, 11,870 other cardiac, 14,580 cerebro-
vascular, 10,000 abdominal/lower limb disease events, and 38,765 non-cardiac related deaths
were observed. As shown in Table 2, the highest incidence rates (>100 events/100,000 person-
years at risk) for individuals with history of depression were found for myocardial infarction,
stable angina, heart failure, transient ischemic attack, and peripheral arterial disease. Individu-
als with new onset depression had the highest incidence rates for the same CVDs as those with
history of depression, with the exception of transient ischemic attack.
After adjustment for cardiovascular risk factors, we found that history of depression was
associated with higher risk of each of the 12 cardiovascular diseases; stable angina (HR = 1.38,
95%CI 1.32–1.45), unstable angina (1.70, 1.60–1.82), myocardial infarction (1.21, 1.16–1.27),
unheralded coronary death (1.23, 1.14–1.32), heart failure (1.18, 1.13–1.24), transient ischemic
attack (1.31, 1.25–1.38), ischemic stroke (1.26, 1.18–1.34), intracerebral haemorrhage (1.30,
1.17–1.45), and peripheral arterial disease (1.24, 1.18–1.30). (Fig 2) Weaker associations were
found with cardiac arrest/sudden cardiac death, subarachnoid haemorrhage, and abdominal
aortic aneurysm.
We found no significant differences in covariate-adjusted risk of any cardiovascular end-
point between men and women with GP-diagnosed history of depression (Fig 3) or new onset
depression (Figure A in S1 File).
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After adjustment for cardiovascular risk factors, we found that new onset depression was
associated with stable angina (HR = 1.46, 95%CI 1.30–1.65), unstable angina (1.62, 1.36–1.92),
unheralded coronary heart disease death (1.30, 1.09–1.56), heart failure (1.17, 1.03–1.32), car-
diac arrest/sudden cardiac death (1.32, 1.04–1.68), transient ischemic attack (1.34, 1.18–1.53),
and initial presentation with peripheral arterial disease (1.30, 1.14–1.48). (Fig 4) Weak associa-
tions were found between new onset depression and initial presentation of myocardial infarc-
tion, ischemic stroke, subarachnoid and intracerebral haemorrhage, and abdominal aortic
aneurysm. The associations with all cardiovascular endpoints did not differ significantly
between history of depression and new onset depression.
Table 1. Cardiovascular disease risk factors among people with and without new onset depression at baseline.
No depression at baseline
(n/N = 1,316,831/1,356,578)†




n (%) n (%) n (%)
Women 604,278 (45.9) 25,381 (63.9) 245,989 (67.0)
Mean age, years (SD) 47.3 (15.1) 47 (15.0) 48.3 (15.6)
Ethnicity*
White 587,711 (90.4) 23,153 (92.8) 219,042 (59.7)
South Asian 19,151 (2.9) 593 (2.4) 4,077 (1.1)
Black 21,150 (3.3) 615 (2.5) 3,673 (1.0)
Socioeconomic status
Least deprived 278,418 (21.1) 7,016 (17.7) 62,384 (17.0)
Most deprived 242,922 (18.4) 9,115 (22.9) 88,687 (24.2)
Smoking*
Non smoker 45,142 (21.9) 1,853 (18.2) 11,706 (3.2)
Ex smoker 72,002 (34.9) 3,142 (30.8) 26,883 (7.3)
Current smoker 88,925 (43.2) 5,193 (51.0) 43,285 (11.8)
Diabetes mellitus 33,390 (2.5) 1,386 (3.5) 14,197 (3.9)
Mean body mass index, kg/m2 (SD) 26.3 (5.0) 26.5 (5.5) 27.0 (5.9)
Mean blood pressure*, mmHg (SD)
Systolic 130.6 (19.1) 128.4 (18.8) 129.0 (19.0)
Diastolic 78.7 (10.2) 77.8 (10.2) 78.0 (10.4)
Mean lipid concentration*, mg/dL (SD)
Total cholesterol 5.4 (1.1) 5.4 (1.2) 5.0 (1.2)
High density lipoprotein 1.4 (0.4) 1.4 (0.4) 1.0 (0.4)
Medication use
Statins 30,217 (2.3) 1,275 (3.2) 15,682 (4.3)
Any blood pressure-lowering drug 178,605 (13.6) 7,671 (19.3) - -
Mean number of consultations in last year (SD) 3.8 (5.0) 10.0 (8.3) 8.0 (8.3)
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HDL, high density lipoprotein; SD; standard deviation; SBP, systolic blood pressure
† This category refers to the reference group from cohort of new onset depression at baseline (total n = 1,356,578): n = 39,747 with depression versus
n = 1,316,831 with no depression at baseline.
* Missing values in the whole sample (1,937,360) for ethnicity = 50.25%; smoking = 84.0%; systolic blood pressure = 60.2%; diastolic blood
pressure = 60.2%; total cholesterol = 90.0% and high density lipoprotein = 95.0%.; Missing values in the study population (1,356,578) for
ethnicity = 36.89%; smoking = 77.7%; systolic blood pressure = 50.0%; diastolic blood pressure = 50.0%; total cholesterol = 89.0% and high density
lipoprotein = 92.7%.
doi:10.1371/journal.pone.0153838.t001
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Sensitivity analyses
Among participants with complete data for ethnicity and alcohol (n = 674,931 new onset
depression, n = 1,018,538 history of depression), adjustment for these two factors, in addition
to cardiovascular risk factors, did not alter the associations. (Figs B and C in S1 File) We
repeated main analyses after exclusion of participants with diabetes at baseline (for history of
depression n = 301,788 and for new onset depression n = 30,877 with diabetes excluded); the
association between history of depression and the 12 CVD endpoints as well as between new
onset depression and the 12 CVD endpoints remained strong, and the magnitude of HRs was
not significantly altered after adjustment for age, gender, and GP practice. (Results not shown)
In addition, adjustment for body mass index (as well as cardiovascular risk factors) produced
estimates of equal magnitude for the association of history of depression and the 12 outcomes,
as well as for new onset depression and the 12 outcomes. (Table B in S1 File)
Discussion
This linked electronic health record study of 1,937,360 patients shows that GP-diagnosed
depression is associated with an increased risk of a wide range of pathologically heterogeneous
cardiac, cerebrovascular, and peripheral vascular diseases in people who were free of cardiovas-
cular disease at baseline. These associations were of similar magnitude across these 12 diseases,
which included those previously studied (such as heart attack and ischemic stroke), as well as
diseases for which there has been little or no previous literature such as stable angina, heart fail-
ure, sudden cardiac death, transient ischemic attack, abdominal aortic aneurysm, and
Table 2. Cumulative incidence rate (IR) of 12 cardiovascular diseases per 100,000 person-years at risk (PYR) among people with new onset
depression at baseline and with history of depression prior to baseline.




New onset depression at baseline
(n/N = 39,747/1,356,578)
N events IR/100,000 PYR N events IR/100,000 PYR N events IR/100,000 PYR
Coronary
Stable angina 7,983 87 3,106 147 279 108
Unstable angina 3,439 38 1,536 73 137 53
Myocardial infarction 11,085 121 3,257 154 285 110
Unheralded coronary death 3,981 44 1,124 53 122 47
Other myocardial
Heart failure 9,132 100 3,026 143 265 102
Cardiac arrest/sudden cardiac death 2,403 26 622 30 70 27
Cerebrovascular
Transient ischaemic attack 7,538 82 2,643 125 247 95
Ischaemic stroke 4,168 46 1,312 62 119 46
Subarachnoid haemorrhage 819 9 315 15 34 13
Intracerebral haemorrhage 1,610 18 533 25 45 17
Abdominal and lower limb
Peripheral arterial disease 7,423 81 2,661 126 261 101
Abdominal aortic aneurysm 2,261 25 550 26 55 21
Total CVD 74,821 819 25,247 1,198 2,322 898
† This category refers to the reference group from cohort 1 -new onset depression at baseline (total n = 1,356,578): n = 39,747 with depression versus
n = 1,316,831 with no depression at baseline.
doi:10.1371/journal.pone.0153838.t002
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peripheral arterial disease. These findings support the theories of complex multifactorial mech-
anisms in the relationship between depression and cardiovascular disease. Additionally, our
results highlight the importance of assessing and managing global cardiovascular risk to pre-
vent cardiovascular diseases in people with depression.
Clinicians manage a large group of patients who have a history of depression (19% of our
sample) and a smaller group with new onset depression (2.9%). To our knowledge, this is the
first large-scale study to examine GP-diagnosed new onset depression as a risk factor of cardio-
vascular disease, as the majority of previous studies[4–6,10] assessed prevalent depression. We
hypothesized that new onset depression may show stronger associations for certain cardiovas-
cular endpoints compared to history of depression (analogous to stronger effects for current as
compared to ex-smokers).[24] While a history of depression points to cumulative, perhaps ath-
erogenic effects, new onset depression may be related to acute events, such as diminished heart
rate variability. We did not observe differential associations with new onset depression.
In this study we contribute more cardiovascular events (greater than 90,000) than any previ-
ous meta-analysis. For example, a meta-analysis of coronary heart disease found 4,016 events
in 21 studies[7], and a meta-analysis of stroke found 8,478 events in 28 studies[5]. Previous
studies have attempted to investigate sex differences[4,25] in the depression-CVD association.
Ours is the first to have the statistical power to reliably demonstrate that the associations do
not differ in women and men. This is clinically relevant as new onset depression was more
common in women (63.9% of cases) than in men.
Fig 2. Hazard ratios (HR) and 95% confidence interval (95%CI) for the association of history of depression with 12 cardiovascular diseases,
adjusted for age, gender, smoking, systolic blood pressure, diabetes, cholesterol, and socio-economic status (94,432 events in 1,937,360 men and
women). Abbreviations: CHD, coronary heart disease; SCD, sudden cardiac death. Vertical dotted line indicates the HRs for total cardiovascular diseases:
HR = 1.28 (95%CI 1.26–1.30).
doi:10.1371/journal.pone.0153838.g002
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We separated out a wider range of cardiac diseases than previous studies and found that
GP-diagnosed depression was strongly associated with incident stable angina and incident
unstable angina, common initial manifestations of cardiovascular disease. Previous studies
have either included angina as a component of aggregate coronary heart disease outcomes
along with myocardial infarction and ischemic heart disease,[6,8] or have excluded [8] stable
angina on the basis that people with mood disorders are more likely to report angina-like chest
pain in the absence of narrowed coronary arteries. However, research suggests that this phe-
nomenon may only occur in depression with co-morbid panic disorders.[26] In our study the
association between new onset depression and initial presentation of myocardial infarction
(MI) became insignificant after adjustment for cardiovascular risk factors, but remained signif-
icant for history of depression. This is in line with a recent meta-analysis[6], which found a
60% increased risk of myocardial infarction in depressed participants; the pooled estimate was
based on 8 studies, of which only 3 excluded prevalent CVD, while the rest showed non-signifi-
cant associations, were based on elderly populations, or on self-reported MI with small sample
sizes. In other meta-analyses,[7,8] fatal and non-fatal MI were grouped with coronary heart
disease death into a single outcome, making comparison with our results difficult.
We found that depression was associated with elevated risk of heart failure, an increasingly
common initial presentation of cardiovascular disease. Few other cohort studies have examined
this association. A cohort of elderly (>70 years) participants found that depression was associ-
ated with increased risk of developing heart failure among women only.[27] We add to current
literature by showing that depression may contribute to the development of heart failure not
only in susceptible, but also in disease-free populations.
We found that depression was associated with incident major, but uncommon, cerebrovas-
cular events (sub-arachnoid haemorrhage, intracerebral haemorrhage) and more common
events (such as transient ischaemic attack). These are novel findings; none of these subtypes of
Fig 3. Hazard ratios (HR) and 95% confidence intervals (95%CI) by gender for the association of history of depression with 12 cardiovascular
diseases, adjusted for age, smoking, systolic blood pressure, diabetes, cholesterol, and socio-economic status (94,432 events in 958,329men
and 979,031 women). P-values for interaction between gender and history of depression: stable angina p = 0.618, unstable angina p = 0.174,
myocardial infarction p = 0.210, unheralded coronary death p = 0.478, heart failure p = 0.101, cardiac arrest/sudden cardiac death p = 0.972,
transient ischaemic attack p = 0.632, ischaemic stroke p = 0.113, subarachnoid haemorrhage p = 0.683, intracerebral haemorrhage p = 0.612,
peripheral arterial disease p = 0.265, abdominal aortic aneurysm p = 0.303. Abbreviation: SCD; sudden cardiac death.
doi:10.1371/journal.pone.0153838.g003
CArdiovascular Research Using LInked Bespoke Studies and Electronic Health Records (CALIBER)
PLOS ONE | DOI:10.1371/journal.pone.0153838 April 22, 2016 10 / 16
cerebrovascular disease was reported in a recent meta-analysis of 28 cohort studies of depres-
sion and cerebrovascular disease;[5] based on pooled estimates across 6 cohorts the meta-anal-
ysis found [5] an association for ischemic stroke of 1.25 (95%CI 1.11–1.40), which overlaps
with our estimates (new onset depression: HR = 1.18, 0.98–1.42; history of depression: 1.31,
1.23–1.40). We found significantly elevated risk of haemorrhagic stroke among those with his-
tory of depression, which may be explained by the larger (9-fold) number of people with a his-
tory of depression compared to new onset depression. The risk of incident transient ischemic
attack was 35% higher among depressed individuals, which has not been previously demon-
strated. Certain meta-analyses [6] and prospective cohort studies[11] aggregated stroke sub-
types due to insufficient numbers, while other studies loosely defined the composition of their
total cerebrovascular endpoints,[12] or only considered one type of stroke,[10] potentially pre-
venting observation of differential associations with depression.
To our knowledge there have not been large scale prospective studies examining the associa-
tion of GP-diagnosed depression with subsequent peripheral arterial disease or abdominal aor-
tic aneurysm in initially healthy populations. Our study shows that depression confers an
elevated risk of initial presentation with peripheral arterial disease, after adjustment for cardio-
vascular risk factors including smoking. History of depression was also associated with abdom-
inal aortic aneurysm. Until recently, abdominal aortic aneurysm was considered a
manifestation of atherosclerosis but the latest evidence suggests an independent, non-athero-
sclerotic pathogenesis and a stronger effect of smoking on vascular disease in the peripheral
Fig 4. Hazard ratios (HR) and 95% confidence interval (95%CI) for the association of new onset depression with 12 cardiovascular diseases,
adjusted for age, gender, smoking, systolic blood pressure, diabetes, cholesterol, and socio-economic status (63,761 events in 1,356,578 men and
women). Abbreviations: CHD; coronary heart disease, SCD; sudden cardiac death. Vertical dotted line indicates the HRs for total cardiovascular diseases:
HR = 1.30 (95%CI 1.24–1.35).
doi:10.1371/journal.pone.0153838.g004
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arteries.[28] Our findings demonstrate a novel association of depression with a vascular condi-
tion, which is pathologically distinct from thrombotic coronary heart disease.
Underlying bio-behavioural pathways
Cardiovascular risk factors demonstrate somewhat specific associations with different cardio-
vascular diseases; for example, people with type II diabetes have been shown to be at lower risk
of subarachnoid haemorrhage, transient ischaemic attack,[29] and risk of abdominal aortic
aneurysm[30], compared to people without diabetes; blood pressure shows markedly different
associations with peripheral arterial disease (strong associations with systolic, weaker with dia-
stolic blood pressure) and abdominal aortic aneurysm (strong associations with diastolic, weak
or non-existent associations with systolic blood pressure[31]). Our findings underscore the sta-
bility of the relationship between depression and cardiovascular disease, and the need for fur-
ther exploration of underlying mechanisms. The relationship between CVD and depression is
likely to be complex, and the bi-directional association between the conditions is important.
For example, lower ‘cardiovascular fitness’ predicts incident depression, which can subse-
quently influence the incidence of CVD per se.(30) All these outcomes, behaviours, and physi-
ological responses are likely to be interrelated and have common mediators. The pathways
may involve differing simultaneous mechanisms, so that simplistic explanations of the relation-
ship may be unhelpful.(30) As well as behavioural and physiological explanations, there is evi-
dence that health behaviours may also differ in people with depression. Smokers with
depression may be less likely to engage in smoking cessation, despite the fact that smoking ces-
sation is associated with an improvement in mood for those with and without psychiatric diag-
noses.(31) There is also evidence that people with depression and CVD risk factors such as
diabetes are less likely to adhere to screening regimes or adhere to interventions to reduce
excess CVD risk such as lipid lowering medications.(32) Individuals with a depressive episode
are also more likely to be unemployed, belong to the most deprived quintiles, have low educa-
tional qualifications, and unstable housing.[32] In our study, however, adjustment for socio-
economic status and cardiovascular risk factors, including smoking, did not significantly alter
our estimate sizes.
Limitations
Each linked electronic health record (EHR) source used has its own limitations, discussed in
detail elsewhere.[16] Missing data for potential confounding or mediating factors such as alco-
hol use and ethnicity necessitated a complete case analysis, which suggested that these factors
were unlikely to explain much of the observed associations. The data are limited to GP-
recorded depression, which reflect incidence, presentation, and recording by GPs. There is a
lack of validation work on depression recording in primary care databases, and evidence sug-
gests that a GP diagnosis of depression has a specificity of 81.3% and a sensitivity of around
50%.[33] Some individuals labelled in their records with depression may not meet criteria for a
major depressive episode. This misclassification bias may lead to an underestimation the
observed association. Individuals with depression in this study had a higher rate of primary
care consultations in the year before study entry compared to those without. We cannot
exclude that the frequency of consultation meant that depressed patients were more likely to be
diagnoses with cardiovascular conditions nor can we exclude that they were seen more fre-
quently because they were developing symptoms of cardiovascular disease. A recent paper
using CALIBER data identified that patients who went on to develop myocardial infarction
had increasing consultations for chest pain in the months prior to their MI.[34] We cannot
address the extent to which the association between depression and cardiovascular disease
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could be mediated through factors not recorded in EHR sources, such as physical activity or
diet. Similarly to national primary care record sources in other countries, we are not able to
obtain imaging results which would allow better phenotypic resolution of different disease end-
points (e.g. distinguish heart failure with and without preserved ejection fraction). Despite
these important limitations the EHR data has an important strength—these are the data used
in clinical practice to make decisions.
Implications
Almost 19% of patients in our population-based study were diagnosed by their GP as having a
history of depression and were at increased risk of all cardiovascular diseases. As the prevalence
and incidence of depression and cardiovascular disease remain high, our observed associations
have clinical importance. Trial evidence is lacking that treatment of depression reduces risk of
cardiac or other cardiovascular endpoints.[35] However there are recent recommendations
from the American Heart Association and American College of Cardiology[36] and from the
Joint British Societies[37] that cardiovascular risk should be estimated in apparently healthy
individuals in order to inform the initiation of preventive medications, such as statins. While
some guidelines for the management of depression recommend assessment of cardiovascular
risk (confined to patients prescribed specific antidepressant drugs[38]), other guidelines[35,39]
on cardiovascular disease prevention are not explicit about management of cardiovascular risk
among individuals with depression. Our findings provide some support for systematic assess-
ment of the overall cardiovascular risk in patients with depression. Our results also have impli-
cations for the design and interpretation of randomised trials on depression and cardiovascular
disease. Since depression was non-specifically associated with many cardiovascular diseases,
clinical trials may benefit from considering inclusion of primary endpoints combining all car-
diovascular diseases, rather than focusing on fatal coronary heart disease and non-fatal myo-
cardial infarction (as in the ENRICHD trial).[35]
In conclusion, this large linked electronic health record study provides strong evidence that
depression is a risk factor for the initial presentation of a range of cardiac, cerebrovascular, and
peripheral arterial diseases, with no evidence of differential effects by gender.
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